中英切换

网站导航

深圳华大智造科技有限公司 版权所有 粤ICP备16117185号

底部电话和二维码

MGI    Statement    Privacy

  • March 2013
    Successful acquisition of U.S. company Complete GenomicsIntense industry competition made us even more determined to acquire the listed company Complete Genomics. We have been able to reduce costs right from the inception stage by utilizing CG's cutting-edge biotechnologies and instrument technologies.
  • July 2014
    The BGISEQ-1000 sequencing systemThe system was approved by the State Food and Drug Administration in 2014, and this development generated much market buzz for related stocks.
  • June 2015
    The Revolocity sequencing systemThe Revolocity is a fully-integrated "super sequencer", with its first users being Mater, a health services provider in Australia, and the Nijmegen University Medical Center in the Netherlands.
  • Oct 2015
    The BGISEQ-500 high-throughput desktop sequencing systemMGI Tech has complete ownership of intellectual property rights to the device. It can satisfy all clinical needs, and at full speed, can complete the entire sequencing process within 24 hours. BGISEQ-500 has received CFDA and CE approval successively. Supports the development of precise medicine and brings the benefits of gene technology to the people.
  • Nov 2016
    The BGISEQ-50 high-throughput desktop sequencing systemBroad array of applications with no constraints in terms of space. Suitable for use at low-pressure, high-altitude environments. Multiple integrated functions are enclosed within its compact and simple structure, and its small footprint makes for easy placement.
  • Apr 2017
    Mobile medical vehicleThe mobile workstation allows for on-site screening for echinococcosis in remote areas, thus providing residents in these areas with improved and convenient testing services.
  • Jul 2017
    ISO 13485MGI receied ISO 13485 approval.
  • Sep 2017
    Circulating tumor cell separator (CTC)Technology and intelligence come together perfectly in this epoch-making clinical trial that enhances the separation and enrichment efficiency by as much as 100,000 times, with a user-oriented, fully-automated, real-time smart cell-seeking technology. The tumor has nowhere to hide!
  • Oct 2017
    MGISEQ-2000 MGISEQ-200 MGIFLP MGIUS-R3Two new sequencers for more power and lower cost, as well as a highly integrated modular NGS workstation and a remote robotic ultrasound system for exploring more possibility of the future.
  • The future is here, with our all-encompassing platform
    We have already kickstarted research and development in many areas, including sequencing, mass spectrometry, and imaging. These R&D efforts will provide full support to various industries and benefit all of society while establishing new benchmarks for emerging Chinese industries.
  • Fully-automated data plant
    Provides real-time overview. Complete bioinformatics equipment sets with full lifecycle allow us to set up platforms and providesolutions and technical assurance for nationwide initiatives like Big Health.

Honor

MGI

BGI was founded in 1999 with the vision of trans-omics for a better life and has since become the largest genomic organization in the world. With the research and business presences based on genetic research achievements and biotech application
in human health, BGI provides the integrated genomics-based services and solutions across a broad range of applications including scientific research, healthcare provision, agriculture and bio-sustainability complying with bioethical principles.

 

MGI Tech Co., Ltd., is a subsidiary of the BGI, which helps BGI to produce biolo gical
equipment that provides real-time information overview and comes with full life- cycle
coverage, such as genetic sequencer, mass spectrometer, medical image platform and
a number of comprehensive solutions. MGI will support BGI with these tools and sol-
utions to promote development of BGI in precision medicine, agriculture and many other
areas. So far, MGI Tech has owned more than 100 of patents and 500 staffs.
.

Our Subsidiaries
MGI Tech has established operation centers in key Chinese cities (Shenzhen, Wuhan, Qingdao, Changchun, Tianjin and Shanghai) and offices across Europe, Australia, the Americas, and Southeast Asia, as it seeks to establish Chinese manufacturing as a leading force in bioscience technologies.

Shenzhen

Shenzhen MGI Tech Co., Ltd.,Shenzhen MGI Tech Co., Ltd., is a subsidiary of the BGI Group. The company produces bioinformatics equipment that provide real-time information overview and comes with full life-cycle coverage.

Hong Kong

MGI Tech Hong KongThe Hong Kong logistics center shall become an integral part of MGI Tech's global supply chain and provide ease of convenience for overseas markets.

Qingdao

The MGI Tech Qingdao Training CenterThe Qingdao Training Center is the regional headquarters, training base, and service base for northern China, and in accordance with the Qingdao Oceans Strategy, serves as an innovation demonstration center for employees nationwide.

Wuhan

Wuhan MGI Tech Co., Ltd.,MGI Tech (Wuhan) is located in Wuhan East Lake High-Tech Development Zone in Hubei. It has volume production platform for instrument with advanced standard and will contribute to promoting bioscience development in Wuhan.

Australia

MGI Tech AustraliaMGI Tech has established an after-sales and training center in Australia, as part of its effort to expand the scale of its global market services and after-sales network.

U.S

MGI Tech U.S.The establishment of an R&D, production and after-sales center at MGI Tech U.S. has helped to greatly optimize the allocation of MGI Tech's innovation resources and contributed to the company's development of a global R&D network.

Latvia

MGI Tech LatviaMGI Tech is stated to establish a competency center, an after-sales center, a training center and a logistics center in Latvia, making the country a key node in its overseas expansion and global service network.
Key MilestonesAutonomous control throughout the platform